BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24530676)

  • 1. Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36).
    O'Malley RG; Bonaca MP; Scirica BM; Murphy SA; Jarolim P; Sabatine MS; Braunwald E; Morrow DA
    J Am Coll Cardiol; 2014 Apr; 63(16):1644-53. PubMed ID: 24530676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimarker Risk Stratification in Patients With Acute Myocardial Infarction.
    O'Donoghue ML; Morrow DA; Cannon CP; Jarolim P; Desai NR; Sherwood MW; Murphy SA; Gerszten RE; Sabatine MS
    J Am Heart Assoc; 2016 May; 5(5):. PubMed ID: 27207959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of natriuretic peptides and midregional proadrenomedullin to cardiac chamber volumes by computed tomography in patients without heart failure: from the ROMICAT Trial.
    Truong QA; Siegel E; Karakas M; Januzzi JL; Bamberg F; Mahabadi AA; Dasdemir S; Brady TJ; Bergmann A; Kunde J; Nagurney JT; Hoffmann U; Koenig W
    Clin Chem; 2010 Apr; 56(4):651-60. PubMed ID: 20185624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Copeptin, MR-proADM and MR-proANP in Predicting Adverse Outcomes, Alone and in Combination with Traditional Severity Scores, a Secondary Analysis in COVID-19 Patients Requiring Intensive Care Admission.
    Varaldo E; Rumbolo F; Prencipe N; Bioletto F; Settanni F; Mengozzi G; Grottoli S; Ghigo E; Brazzi L; Montrucchio G; Berton AM
    J Clin Med; 2024 Mar; 13(7):. PubMed ID: 38610784
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarkers to improve functional outcome prediction after ischemic stroke: Results from the SICFAIL, STRAWINSKI, and PREDICT studies.
    Montellano FA; Rücker V; Ungethüm K; Penalba A; Hotter B; Giralt M; Wiedmann S; Mackenrodt D; Morbach C; Frantz S; Störk S; Whiteley WN; Kleinschnitz C; Meisel A; Montaner J; Haeusler KG; Heuschmann PU
    Eur Stroke J; 2024 May; ():23969873241250272. PubMed ID: 38711254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonantithrombotic medical options in acute coronary syndromes: old agents and new lines on the horizon.
    Soukoulis V; Boden WE; Smith SC; O'Gara PT
    Circ Res; 2014 Jun; 114(12):1944-58. PubMed ID: 24902977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study.
    Morton AC; Rothman AM; Greenwood JP; Gunn J; Chase A; Clarke B; Hall AS; Fox K; Foley C; Banya W; Wang D; Flather MD; Crossman DC
    Eur Heart J; 2015 Feb; 36(6):377-84. PubMed ID: 25079365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute coronary syndromes.
    Kotecha T; Rakhit RD
    Clin Med (Lond); 2016 Dec; 16(Suppl 6):s43-s48. PubMed ID: 27956440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH.
    Kriechbaum SD; Scherwitz L; Wiedenroth CB; Rudolph F; Wolter JS; Haas M; Fischer-Rasokat U; Rolf A; Hamm CW; Mayer E; Guth S; Keller T; Konstantinides SV; Lankeit M; Liebetrau C
    ERJ Open Res; 2020 Oct; 6(4):. PubMed ID: 33263045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular risk factors and clinical presentation in acute coronary syndromes.
    Rosengren A; Wallentin L; Simoons M; Gitt AK; Behar S; Battler A; Hasdai D
    Heart; 2005 Sep; 91(9):1141-7. PubMed ID: 16103541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive Value of Pro-BNP for Heart Failure Readmission after an Acute Coronary Syndrome.
    Cordero A; Martínez Rey-Rañal E; Moreno MJ; Escribano D; Moreno-Arribas J; Quintanilla MA; Zuazola P; Núñez J; Bertomeu-González V
    J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33924437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.
    Dyhl-Polk A; Schou M; Vistisen KK; Sillesen AS; Serup-Hansen E; Faber J; Klausen TW; Bojesen SE; Vaage-Nilsen M; Nielsen DL
    Oncologist; 2021 Mar; 26(3):e403-e413. PubMed ID: 32959474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analyzing the Release of Copeptin from the Heart in Acute Myocardial Infarction Using a Transcoronary Gradient Model.
    Boeckel JN; Oppermann J; Anadol R; Fichtlscherer S; Zeiher AM; Keller T
    Sci Rep; 2016 Feb; 6():20812. PubMed ID: 26864512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimorbidity, polypharmacy, and drug-drug-gene interactions following a non-ST elevation acute coronary syndrome: analysis of a multicentre observational study.
    Turner RM; de Koning EM; Fontana V; Thompson A; Pirmohamed M
    BMC Med; 2020 Nov; 18(1):367. PubMed ID: 33234119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Coronary Syndrome Subphenotypes Based on Repeated Biomarker Measurements in Relation to Long-Term Mortality Risk.
    de Bakker M; Scholte NTB; Oemrawsingh RM; Umans VA; Kietselaer B; Schotborgh C; Ronner E; Lenderink T; Aksoy I; van der Harst P; Asselbergs FW; Maas A; Oude Ophuis AJ; Krenning B; de Winter RJ; The SHK; Wardeh AJ; Hermans W; Cramer GE; van Schaik RH; de Rijke YB; Akkerhuis KM; Kardys I; Boersma E;
    J Am Heart Assoc; 2024 Jan; 13(2):e031646. PubMed ID: 38214281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischemic Pre-Conditioning is Present in Patients with Non-ST Elevation Myocardial Infarction and ECG Derived Moderate Obstructive Sleep Apnea.
    Borczynski E; Suba S; Mackin LA; Mortara DW; Badilini F; Rodway GW; Pelter MM
    J Cardiovasc Nurs; 2023; 38(3):299-306. PubMed ID: 37027135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Occurrence of Transient Myocardial Ischemic Events among Non-ST Segment Elevation Acute Coronary Syndrome Patients Before or After Invasive Coronary Angiography.
    Suba S; Carey MG; Pelter MM
    Crit Pathw Cardiol; 2024 Mar; ():. PubMed ID: 38578970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of heart rate in hospitalized patients presenting with myocardial infarction.
    Fácila L; Morillas P; Quiles J; Soria F; Cordero A; Mazón P; Anguita M; Martín-Luengo C; Gonzalez-Juanatey JR; Bertomeu V;
    World J Cardiol; 2012 Jan; 4(1):15-9. PubMed ID: 22279600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Convalescent Growth Differentiation Factor-15 and Long-Term Outcomes after an Acute Coronary Syndrome.
    Greer CE; Chew-Harris J; Adamson PD; Pemberton CJ; Pickering JW; Pilbrow AP; Frampton CM; Troughton RW; Doughty RN; Richards AM
    J Appl Lab Med; 2024 Apr; ():. PubMed ID: 38635817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased myocardial expression of angiopoietin-2 in patients undergoing urgent surgical revascularization for acute coronary syndromes.
    Fam NP; Arab S; Billia F; Han R; Proteau G; Latter D; Errett L; Bonneau D; Dunne R; Liu PP; Stewart DJ
    Can J Cardiol; 2010; 26(7):365-70. PubMed ID: 20847963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.